We proudly announce that the Reviewer of the Month Award for February 2023 goes to Chris Labaki, MD.
As a means to promote the hard work and dedication invested “behind the scenes” to improve scientific publications, each month, BiomolBiomed Editors select a reviewer who performed the best amongst all the reviewers in the current month. Selection is based on the quality, thoroughness, and timeliness of the review. It is a difficult task for our Editors, as they try not to underestimate the time and efforts of each of the reviewers who reviewed for the BiomolBiomed in the current month.
Dr. Chris Labaki is a post-doctoral research fellow at Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, working under the mentorship of Drs. Toni K. Choueiri, Eliezer M. Van Allen and David A. Braun.
He has a particular research interest in the clinical and translational investigation of genitourinary malignancies, with a focus on kidney cancer. More specifically, his current work is focused on the identification of genomic and transcriptomic determinants of resistance to immune checkpoint inhibitors in renal cell carcinoma (RCC) and the molecular characterization of rare forms of kidney cancer.
We asked Dr. Labaki about the importance and other aspects of the peer-review process in general:
A thorough and comprehensive peer-review process is essential to ensure that every published work truly reflects adequate science and reliable findings. It helps to improve in a constructive way the scientific work being done and to point out eventual flaws, eventually playing a major role in shaping scientific and medical knowledge.
BiomolBiomed congratulates Dr. Chris Labaki and wishes him many awards and recognitions in the future.
Editor: Ermina Vukalic
Leave a Reply